We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMS icon
1401
CMS Energy
CMS
$23B
$2.11M ﹤0.01%
+34,400
New +$2.11M
TOACW
1402
CALL
DELISTED
Talon 1 Acquisition Corp. Warrant
TOACW
$2.11M ﹤0.01%
200,000
HROW icon
1403
Harrow
HROW
$1.47B
$2.11M ﹤0.01%
99,629
-2,401
-2% -$40.9K
SCUA.WS
1404
CALL
DELISTED
Sculptor Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SCUA.WS
$2.1M ﹤0.01%
199,997
NIOBW
1405
CALL
NioCorp Developments Ltd Warrant
NIOBW
$51M
$2.1M ﹤0.01%
+330,000
New +$244K
ASBPW
1406
CALL
Aspire Biopharma Warrant
ASBPW
$579K
$2.1M ﹤0.01%
199,998
DPCSW
1407
CALL
DELISTED
DP Cap Acquisition Corp I Warrants
DPCSW
$2.09M ﹤0.01%
200,000
AMG icon
1408
Affiliated Managers Group
AMG
$9.78B
$2.09M ﹤0.01%
+14,673
New +$2.32M
SHC icon
1409
Sotera Health
SHC
$5.06B
$2.09M ﹤0.01%
+116,597
New +$1.95M
OGE icon
1410
OGE Energy
OGE
$10.2B
$2.09M ﹤0.01%
55,400
-22,400
-29% -$842K
FIACW
1411
CALL
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
$2.08M ﹤0.01%
200,000
INFA
1412
DELISTED
Informatica
INFA
$2.08M ﹤0.01%
+126,770
New +$2.15M
NPABW
1413
CALL
DELISTED
New Providence Acquisition Corp. II Warrant
NPABW
$2.07M ﹤0.01%
200,000
BRD.WS
1414
CALL
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$2.07M ﹤0.01%
200,000
FRBNW
1415
CALL
DELISTED
Forbion European Acquisition Corp. Warrants
FRBNW
$2.07M ﹤0.01%
196,203
KN icon
1416
Knowles
KN
$3.07B
$2.06M ﹤0.01%
121,456
-64,184
-35% -$1.12M
HY icon
1417
Hyster-Yale Materials Handling
HY
$615M
$2.06M ﹤0.01%
+41,384
New +$1.52M
APGB.WS
1418
CALL
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$2.06M ﹤0.01%
200,739
DMYY
1419
DELISTED
dMY Squared
DMYY
$2.06M ﹤0.01%
200,698
DADA
1420
DELISTED
Dada Nexus
DADA
$2.05M ﹤0.01%
242,339
+151,742
+167% +$1.65M
V icon
1421
PUT
Visa
V
$697B
$2.05M ﹤0.01%
9,100
-55,500
-86% -$12.4M
REAL icon
1422
The RealReal
REAL
$1.44B
$2.05M ﹤0.01%
1,625,683
-2,566,665
-61% -$3.73M
BLEUW
1423
CALL
DELISTED
bleuacacia ltd Warrants
BLEUW
$2.05M ﹤0.01%
200,000
GTHX
1424
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2.05M ﹤0.01%
763,376
-231,612
-23% -$1.11M
VRNS icon
1425
Varonis Systems
VRNS
$5.13B
$2.04M ﹤0.01%
+78,445
New +$2.05M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.